MiRNAs as non-invasive biomarkers for lung cancer diagnosis

Paola Ulivi, Wainer Zoli

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent stable and reproducible markers for numerous solid tumors, including lung cancer, and have been hypothesized as non-invasive diagnostic markers. Serum, plasma or whole peripheral blood can be used as starting material, and several methodological approaches have been proposed to evaluate miRNA expression. The present review provides an in depth summary of current knowledge on circulating miRNAs in different types of biological samples used as diagnostic markers of lung cancer. We also evaluate the diagnostic accuracy of each miRNA or group of miRNAs in relation to the different housekeeping miRNAs used. Finally, the limitations and potential of miRNA analysis are discussed.

Original languageEnglish
Pages (from-to)8220-8237
Number of pages18
JournalMolecules
Volume19
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Biomarkers
MicroRNAs
Lung Neoplasms
Housekeeping
Delayed Diagnosis
Tumors
Cause of Death
Neoplasms
Blood
Plasmas
Mortality
Serum

Keywords

  • Diagnosis
  • MiRNAs
  • Non-invasive biomarker
  • NSCLC

ASJC Scopus subject areas

  • Organic Chemistry
  • Medicine(all)

Cite this

MiRNAs as non-invasive biomarkers for lung cancer diagnosis. / Ulivi, Paola; Zoli, Wainer.

In: Molecules, Vol. 19, No. 6, 2014, p. 8220-8237.

Research output: Contribution to journalArticle

Ulivi, Paola ; Zoli, Wainer. / MiRNAs as non-invasive biomarkers for lung cancer diagnosis. In: Molecules. 2014 ; Vol. 19, No. 6. pp. 8220-8237.
@article{212deee91ad545eab07f458213b11ca8,
title = "MiRNAs as non-invasive biomarkers for lung cancer diagnosis",
abstract = "Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent stable and reproducible markers for numerous solid tumors, including lung cancer, and have been hypothesized as non-invasive diagnostic markers. Serum, plasma or whole peripheral blood can be used as starting material, and several methodological approaches have been proposed to evaluate miRNA expression. The present review provides an in depth summary of current knowledge on circulating miRNAs in different types of biological samples used as diagnostic markers of lung cancer. We also evaluate the diagnostic accuracy of each miRNA or group of miRNAs in relation to the different housekeeping miRNAs used. Finally, the limitations and potential of miRNA analysis are discussed.",
keywords = "Diagnosis, MiRNAs, Non-invasive biomarker, NSCLC",
author = "Paola Ulivi and Wainer Zoli",
year = "2014",
doi = "10.3390/molecules19068220",
language = "English",
volume = "19",
pages = "8220--8237",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - MiRNAs as non-invasive biomarkers for lung cancer diagnosis

AU - Ulivi, Paola

AU - Zoli, Wainer

PY - 2014

Y1 - 2014

N2 - Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent stable and reproducible markers for numerous solid tumors, including lung cancer, and have been hypothesized as non-invasive diagnostic markers. Serum, plasma or whole peripheral blood can be used as starting material, and several methodological approaches have been proposed to evaluate miRNA expression. The present review provides an in depth summary of current knowledge on circulating miRNAs in different types of biological samples used as diagnostic markers of lung cancer. We also evaluate the diagnostic accuracy of each miRNA or group of miRNAs in relation to the different housekeeping miRNAs used. Finally, the limitations and potential of miRNA analysis are discussed.

AB - Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent stable and reproducible markers for numerous solid tumors, including lung cancer, and have been hypothesized as non-invasive diagnostic markers. Serum, plasma or whole peripheral blood can be used as starting material, and several methodological approaches have been proposed to evaluate miRNA expression. The present review provides an in depth summary of current knowledge on circulating miRNAs in different types of biological samples used as diagnostic markers of lung cancer. We also evaluate the diagnostic accuracy of each miRNA or group of miRNAs in relation to the different housekeeping miRNAs used. Finally, the limitations and potential of miRNA analysis are discussed.

KW - Diagnosis

KW - MiRNAs

KW - Non-invasive biomarker

KW - NSCLC

UR - http://www.scopus.com/inward/record.url?scp=84903289253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903289253&partnerID=8YFLogxK

U2 - 10.3390/molecules19068220

DO - 10.3390/molecules19068220

M3 - Article

VL - 19

SP - 8220

EP - 8237

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 6

ER -